La. Admin. Code tit. 35 § I-1725

Current through Register Vol. 50, No. 11, November 20, 2024

Section I-1725 - [Effective until 12/5/2024] Controlled Medication

A. Controlled medications are permitted in Louisiana as set forth in the Controlled Therapeutic Medication Schedule for Horses - Version 4.1 as published by the Association of Racing Commissioners International, Inc. and shall only be administered as therein prescribed and regulated at the threshold levels set forth in said list, with the following exceptions:

1. The following medications may only be used intravenously on thoroughbreds at the specified dosages, either as one of the following medications administered at a withdrawal time of 24 hours at the specified dosages or as a combination of two of the following medications administered within 48 hours at a withdrawal time of 48 hours for the first medication and at a withdrawal time of 24 hours for the second medication at the specified dosages:

a. phenylbutazone at a dosage of up to 2 grams;

b. Banamine, or flunixin meglumine, at a dosage of up to 500 milligrams; and

c. Ketofen, or ketoprofen, at a dosage of up to 1 gram.

2. The following medications may only be used one at a time intravenously on thoroughbreds and may not be used in combination at the specified withdrawal times and dosages:

a. dexamethasone at a dosage of up to 20 milligrams with a withdrawal time of 48 hours; and

b. triamcinolone at a dosage of up to 10 milligrams with a withdrawal time of 72 hours.

3. The following medications may only be used one at a time intra-articularly on thoroughbreds, or as joint injections, at a withdrawal time of 7 days at the specified dosages and may not be used in any combination at a withdrawal time of 7 days at the specified dosages:

a. triamcinolone at a dosage of up to 20 milligrams;

b. Depo-Medrol, or methylprednisolone acetate, at a dosage of up to 200 milligrams; and

c. betamethasone at a dosage of up to 60 milligrams;

4. The following medications may only be used on thoroughbreds at the specified withdrawal times and dosages:

a. dimethyl sulfoxide (DMSO), administered intravenously, at a dosage of up to 100 milliliters with a withdrawal time of 24 hours;

b. methocarbamol at a dosage of up to 2 grams with a withdrawal time of 48 hours;

c. dantrolene at a dosage of up to 500 milligrams with a withdrawal time of 24 hours;

d. acepromozine, administered orally or intravenously, at a dosage of up to 50 milligrams with a withdrawal time of 48 hours;

e. xylazine at a dosage of up to 300 milligrams with a withdrawal time of 24 hours;

f. detomidine at a dosage of up to 10 milligrams with a withdrawal time of 24 hours;

g. Ventipulmin, or clenbuterol hydrochloride, at a dosage of up to 725 micrograms with a withdrawal time of 72 hours;

h. butorphanol at a dosage of up to 10 milligrams with a withdrawal time of 48 hours;

i. omeprazole with no withdrawal time;

j. calcium gluconate or calcium-magnesium-phosphorous-potassium-dextrose solution (CMPK) with no withdrawal time; and

k. acetylcysteine with no withdrawal time;

B. The Controlled Therapeutic Medication Schedule for Horses - Version 4.1 as published by the Association of Racing Commissioners International, Inc., shall be maintained on the commission website and at the domicile office and be made available to the public upon request.

La. Admin. Code tit. 35, § I-1725

Adopted by the Racing Commission in 1971, promulgated by the Department of Commerce, Racing Commission, LR 2:449 (December 1976), amended LR 3:45 (January 1977), LR 4:287 (August 1978), amended by the Office of the Governor, Division of Administration, Racing Commission, LR 41:1672 (September 2015), Amended LR 50, exp. 12/5/2024 (Emergency).

AUTHORITY NOTE: Promulgated in accordance with R.S. 4:148.